Lyra Therapeutics, Inc. (LYRA) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$28.92M | +69.0% |
| 2024 | -$93.44M | -49.1% |
| 2023 | -$62.68M | -13.4% |
| 2022 | -$55.28M | -27.0% |
| 2021 | -$43.51M | -96.7% |
| 2020 | -$22.13M | -35.7% |
| 2019 | -$16.31M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$28.92M | +69.0% |
| 2024 | -$93.44M | -49.1% |
| 2023 | -$62.68M | -13.4% |
| 2022 | -$55.28M | -27.0% |
| 2021 | -$43.51M | -96.7% |
| 2020 | -$22.13M | -35.7% |
| 2019 | -$16.31M | — |